[PHARMA] QoQ Quarter Result on 30-Jun-2023 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
11-Aug-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Jun-2023 [#2]
Profit Trend
QoQ- -25.94%
YoY- 171.61%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 964,959 789,807 885,486 848,734 880,454 862,720 924,681 2.88%
PBT 39,044 -22,099 -56,259 6,342 9,193 -638,395 15,589 84.32%
Tax -12,865 -9,980 7,212 -4,018 -6,427 -5,802 -6,212 62.40%
NP 26,179 -32,079 -49,047 2,324 2,766 -644,197 9,377 98.14%
-
NP to SH 25,646 -32,721 -49,339 1,961 2,648 -644,390 8,617 106.77%
-
Tax Rate 32.95% - - 63.36% 69.91% - 39.85% -
Total Cost 938,780 821,886 934,533 846,410 877,688 1,506,917 915,304 1.70%
-
Net Worth -272,392 -281,734 -245,740 -137,571 -142,812 -248,894 411,327 -
Dividend
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Div - - - - - - 7,859 -
Div Payout % - - - - - - 91.21% -
Equity
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Net Worth -272,392 -281,734 -245,740 -137,571 -142,812 -248,894 411,327 -
NOSH 1,441,229 1,441,229 1,441,229 1,310,208 1,310,208 1,309,126 1,309,126 6.61%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 2.71% -4.06% -5.54% 0.27% 0.31% -74.67% 1.01% -
ROE 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.09% -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 66.95 57.75 65.94 64.78 67.20 65.86 70.59 -3.46%
EPS 1.78 -2.39 -3.67 0.15 0.20 -49.19 0.66 93.63%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.60 -
NAPS -0.189 -0.206 -0.183 -0.105 -0.109 -0.19 0.314 -
Adjusted Per Share Value based on latest NOSH - 1,310,208
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
RPS 66.95 54.80 61.44 58.89 61.09 59.86 64.16 2.87%
EPS 1.78 -2.27 -3.42 0.14 0.18 -44.71 0.60 106.32%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.55 -
NAPS -0.189 -0.1955 -0.1705 -0.0955 -0.0991 -0.1727 0.2854 -
Price Multiplier on Financial Quarter End Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 30/12/22 30/09/22 -
Price 0.355 0.385 0.435 0.37 0.285 0.545 0.515 -
P/RPS 0.53 0.67 0.66 0.57 0.42 0.83 0.73 -19.20%
P/EPS 19.95 -16.09 -11.84 247.21 141.02 -1.11 78.29 -59.77%
EY 5.01 -6.21 -8.45 0.40 0.71 -90.26 1.28 148.15%
DY 0.00 0.00 0.00 0.00 0.00 0.00 1.17 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 1.64 -
Price Multiplier on Announcement Date
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Date 27/05/24 29/02/24 29/11/23 11/08/23 18/05/23 27/02/23 24/11/22 -
Price 0.39 0.37 0.405 0.42 0.38 0.44 0.55 -
P/RPS 0.58 0.64 0.61 0.65 0.57 0.67 0.78 -17.90%
P/EPS 21.92 -15.46 -11.02 280.62 188.02 -0.89 83.61 -59.00%
EY 4.56 -6.47 -9.07 0.36 0.53 -111.80 1.20 143.31%
DY 0.00 0.00 0.00 0.00 0.00 0.00 1.09 -
P/NAPS 0.00 0.00 0.00 0.00 0.00 0.00 1.75 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment